Product Code: 222090DB
Affecting millions around the world, sickle cell disease (SCD) in the United States disproportionately affects African Americans and Hispanic Americans at a rate of 1 in 365 or 16,300 births, respectively.
Since the first edition of this book more than 20 years ago, significant advances have made this is a truly exciting time with new therapies and curative options. Transfusion remains a critical tool in the therapeutic armamentarium, and this book offers the most recent research and best clinical practices from leading experts, including something for everyone involved in the treatment of SCD patients-clinicians, laboratory staff, and administrators.
Eleven chapters cover the following broad topic areas:
Edited by: Jennifer Andrews, MD, MSc, and Marisa B. Marques, MD
AABB, 2022, digital, 292 pages
Member price: $80
Nonmember price: $110
View Table of Contents (pdf)
View Preface (pdf)
View Sample Pages (pdf)